BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8877397)

  • 1. Increased plasma concentrations of circulating intercellular adhesion molecule-1 (cICAM-1) in patients with necrotizing pancreatitis.
    Kaufmann P; Tilz GP; Smolle KH; Demel U; Krejs GJ
    Immunobiology; 1996 Jul; 195(2):209-19. PubMed ID: 8877397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time course of plasma soluble intercellular adhesion molecule-1 (sICAM-1) is related to severity of acute pancreatitis.
    Kaufmann P; Demel U; Tilz GP; Krejs GJ
    Hepatogastroenterology; 1999; 46(28):2565-71. PubMed ID: 10522042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum adhesion molecules in acute pancreatitis: time course and early assessment of disease severity.
    Pezzilli R; Corsi MM; Barassi A; Morselli-Labate AM; D'Alessandro A; Dogliotti G; Fantini L; Malesci A; Corinaldesi R; Melzi d'Eril G
    Pancreas; 2008 Jul; 37(1):36-41. PubMed ID: 18580442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation of serial measurements of plasma-soluble intercellular adhesion molecule-1 to severity of acute pancreatitis.
    Kaufmann P; Smolle KH; Brunner GA; Demel U; Tilz GP; Krejs GJ
    Am J Gastroenterol; 1999 Sep; 94(9):2412-6. PubMed ID: 10484001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A form of circulating ICAM-1 in human serum.
    Rothlein R; Mainolfi EA; Czajkowski M; Marlin SD
    J Immunol; 1991 Dec; 147(11):3788-93. PubMed ID: 1682385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating forms of ICAM-3 (cICAM-3). Elevated levels in autoimmune diseases and lack of association with cICAM-1.
    Martin S; Rieckmann P; Melchers I; Wagner R; Bertrams J; Voskuyl AE; Roep BO; Zielasek J; Heidenthal E; Weichselbraun I
    J Immunol; 1995 Feb; 154(4):1951-5. PubMed ID: 7836774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating levels of intercellular adhesion molecule-1 (ICAM-1) and soluble interleukin 2 receptors (IL-2R) in patients with B cell chronic lymphocytic leukaemia.
    Musolino C; Alonci A; Allegra A; Bellomo G; Spatari G; Pernice F; Squadrito G; Quartarone C; Tringali O; Quartarone M
    Riv Eur Sci Med Farmacol; 1996; 18(3):113-8. PubMed ID: 9177607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Reduction of local and systemic complications of acute pancreatitis by monoclonal antibody to ICAM-1].
    Werner J; Hartwig W; Schmidt E; Gebhard MM; Herfarth C; Klar E
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):725-9. PubMed ID: 14518349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of circulating adhesion molecules ICAM-1, VCAM-1 and E-selectin in Wegener's granulomatosis, systemic lupus erythematosus and chronic renal failure.
    Mrowka C; Sieberth HG
    Clin Nephrol; 1995 May; 43(5):288-96. PubMed ID: 7543387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum levels of circulating ICAM-1 are increased in Hodgkin's disease.
    Gruss HJ; Dölken G; Brach MA; Mertelsmann R; Herrmann F
    Leukemia; 1993 Aug; 7(8):1245-9. PubMed ID: 8102418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential patterns of circulating intercellular adhesion molecule-1 (cICAM-1) and vascular cell adhesion molecule-1 (cVCAM-1) during liver allograft rejection.
    Lang T; Krams SM; Villanueva JC; Cox K; So S; Martinez OM
    Transplantation; 1995 Feb; 59(4):584-9. PubMed ID: 7533349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating intercellular adhesion molecule-1 in chronic liver disease and hepatocellular carcinoma.
    Huang YS; Wu JC; Chan CY; Chao Y; Chang FY; Lee SD
    Zhonghua Yi Xue Za Zhi (Taipei); 1999 Aug; 62(8):487-95. PubMed ID: 10462824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating ICAM-1 is increased in septic shock.
    Sessler CN; Windsor AC; Schwartz M; Watson L; Fisher BJ; Sugerman HJ; Fowler AA
    Am J Respir Crit Care Med; 1995 May; 151(5):1420-7. PubMed ID: 7735595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Circulating adhesion molecules (cICAM-1, lcVCAM-1) in patients with suspected inflammatory heart muscle disease].
    Klein RM; Breuer R; Mundhenke M; Schwartzkopff B; Strauer BE
    Z Kardiol; 1998 Feb; 87(2):84-93. PubMed ID: 9556870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated concentrations of circulating adhesion molecules and their association with microvascular complications in insulin-dependent diabetes mellitus.
    Fasching P; Veitl M; Rohac M; Streli C; Schneider B; Waldhäusl W; Wagner OF
    J Clin Endocrinol Metab; 1996 Dec; 81(12):4313-7. PubMed ID: 8954033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is dialysis membrane type responsible for increased circulating adhesion molecules during chronic hemodialysis?
    Mrowka C; Heintz B; Sieberth HG
    Clin Nephrol; 1999 Nov; 52(5):312-21. PubMed ID: 10584995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early increase in levels of soluble inter-cellular adhesion molecule-1 (sICAM-1); potential risk factor for the acute coronary syndromes.
    O'Malley T; Ludlam CA; Riemermsa RA; Fox KA
    Eur Heart J; 2001 Jul; 22(14):1226-34. PubMed ID: 11440495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Circulating ICAM-1 in sera of renal allograft recipients in monitoring of acute rejection].
    Fu Y; Wang M; Ji X
    Zhonghua Yi Xue Za Zhi; 1998 Jun; 78(6):452-3. PubMed ID: 10923510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated levels of circulating intercellular adhesion molecule-3 (cICAM-3) in Psoriasis.
    Griffiths CE; Boffa MJ; Gallatin WM; Martin S
    Acta Derm Venereol; 1996 Jan; 76(1):2-5. PubMed ID: 8721479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating ICAM-1 levels in bronchial asthma and the effect of inhaled corticosteroids.
    Cengizlier R; Demirpolat E; Tülek N; Cakmak F
    Ann Allergy Asthma Immunol; 2000 May; 84(5):539-41. PubMed ID: 10831009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.